Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis

Autor:	F Hirano, Yukihiko Saeki, Yasutaka Okita, Shiro Ohshima, S Ito, Shigeto Tohma, E. Suematsu, M Katayama, Hirokazu Takaoka, Y. Harada, S. Teshigawara, Y. Suenaga, Akiko Okamoto, Hidetoshi Matsuoka, Daijiro Kabata, M. Yoshimura, Chikako Udagawa, Kentaro Kuzuya, Y Yoshida, Shigeru Yoshizawa, Koichiro Ohmura, K. Takahi, K Isoda, Eri Oguro, A. Taura, Toshihiro Matsui
Rok vydání:	2020
Předmět:	030203 arthritis & rheumatology business.industry Immunology Tumor Necrosis Factor alpha-Induced Protein 3 General Medicine medicine.disease TNFAIP3 Infliximab Etanercept Proinflammatory cytokine 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure Rheumatology Rheumatoid arthritis medicine Adalimumab Immunology and Allergy 030212 general & internal medicine business B cell medicine.drug
Zdroj:	Scandinavian Journal of Rheumatology. 49:253-255
ISSN:	1502-7732 0300-9742
Popis:	Biological disease-modifying anti-rheumatic drugs (bDMARDs) against pathogenic proinflammatory cytokines and lymphocytes, such as tumour necrosis factor-α (TNF-α), interleukin-6, T cells and B cell...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3fd6237ee0b06922d1b06a06ba603048 https://doi.org/10.1080/03009742.2020.1716992 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.